Zevra Therapeutics, Inc. (ZVRA) Profit Margin
Zevra Therapeutics, Inc. (ZVRA) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | -191.00% |
| 2020-12-31 | -96.03% |
| 2021-12-31 | -29.86% |
| 2022-12-31 | -89.65% |
| 2023-12-31 | -167.69% |
| 2024-12-31 | -447.08% |
| 2025-12-31 | 78.15% |
How ZVRA compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| KRYS | Krystal Biotech Inc. | 52.64% |
| UTHR | United Therapeutics Corporation | 41.94% |
| EXEL | Exelixis Inc. | 33.73% |
| VRTX | Vertex Pharmaceuticals Incorporated | 32.94% |
| LLY | Eli Lilly and Company | 31.67% |
These are five companies in the same sector as ZVRA with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Zevra Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("ZVRA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ZVRA | $11.18 | -2.27% | 0.71M |
| 3 | ||||
| 4 | ||||
| 5 |